MGX vs. ALAB
MGX (Metagenomi, Inc) and ALAB (Astera Labs, Inc.) are both stocks. MGX operates in Biotechnology (Healthcare), while ALAB operates in Semiconductors (Technology). Over the past year, MGX returned -24.43% vs 282.87% for ALAB. At a 0.21 correlation, their price movements are largely independent.
Performance
MGX vs. ALAB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MGX achieves a -17.90% return, which is significantly lower than ALAB's 113.85% return.
MGX
- 1D
- 1.53%
- 1M
- -4.32%
- YTD
- -17.90%
- 6M
- -14.47%
- 1Y
- -24.43%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ALAB
- 1D
- 11.14%
- 1M
- 75.53%
- YTD
- 113.85%
- 6M
- 148.89%
- 1Y
- 282.87%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MGX vs. ALAB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
MGX Metagenomi, Inc | -17.90% | -55.12% | -66.82% |
ALAB Astera Labs, Inc. | 113.85% | 25.60% | 113.53% |
Correlation
The correlation between MGX and ALAB is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Mar 21, 2024 | 0.21 |
Fundamentals
MGX:
$49.98M
ALAB:
$64.45B
MGX:
-$2.29
ALAB:
$1.48
MGX:
2.23
ALAB:
64.04
MGX:
0.36
ALAB:
43.14
MGX:
$22.33M
ALAB:
$1.00B
MGX:
-$4.05M
ALAB:
$760.99M
MGX:
-$86.61M
ALAB:
$253.12M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MGX vs. ALAB — Risk / Return Rank
MGX
ALAB
MGX vs. ALAB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Metagenomi, Inc (MGX) and Astera Labs, Inc. (ALAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MGX | ALAB | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.33 | 3.02 | -3.35 |
Sortino ratioReturn per unit of downside risk | -0.03 | 3.06 | -3.09 |
Omega ratioGain probability vs. loss probability | 1.00 | 1.39 | -0.40 |
Calmar ratioReturn relative to maximum drawdown | -0.35 | 4.85 | -5.20 |
Martin ratioReturn relative to average drawdown | -0.52 | 9.58 | -10.10 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MGX | ALAB | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.33 | 3.02 | -3.35 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.51 | 1.32 | -1.83 |
Drawdowns
MGX vs. ALAB - Drawdown Comparison
The maximum MGX drawdown since its inception was -89.80%, which is greater than ALAB's maximum drawdown of -63.69%. Use the drawdown chart below to compare losses from any high point for MGX and ALAB.
Loading charts...
Drawdown Indicators
| MGX | ALAB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.80% | -63.69% | -26.11% |
Max Drawdown (1Y)Largest decline over 1 year | -62.69% | -60.19% | -2.50% |
Current DrawdownCurrent decline from peak | -89.14% | 0.00% | -89.14% |
Average DrawdownAverage peak-to-trough decline | -73.81% | -29.90% | -43.91% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.08% | 30.49% | +11.59% |
Volatility
MGX vs. ALAB - Volatility Comparison
The current volatility for Metagenomi, Inc (MGX) is 10.95%, while Astera Labs, Inc. (ALAB) has a volatility of 29.37%. This indicates that MGX experiences smaller price fluctuations and is considered to be less risky than ALAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MGX | ALAB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.95% | 29.37% | -18.42% |
Volatility (6M)Calculated over the trailing 6-month period | 40.12% | 70.88% | -30.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 73.80% | 94.42% | -20.62% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 115.29% | 92.63% | +22.66% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 115.29% | 92.63% | +22.66% |
Dividends
MGX vs. ALAB - Dividend Comparison
Neither MGX nor ALAB has paid dividends to shareholders.
Financials
MGX vs. ALAB - Financials Comparison
This section allows you to compare key financial metrics between Metagenomi, Inc and Astera Labs, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MGX and ALAB have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ALAB has higher volatility (29.37%) compared to MGX (10.95%). In terms of maximum drawdown, MGX dropped -89.80% vs ALAB's -63.69%.
ALAB currently has the higher Sharpe Ratio (3.02 vs -0.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MGX and ALAB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer